# Vilas Ventures

> Vilas Ventures is a VC fund in Fort Lauderdale backing Biotechnology and Software. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Fort Lauderdale, United States
- Total investments: 3
- Last investment: Aug 2026
- Lead investor: 67%
- Last updated: Aug 2026
- Website: https://vilasventures.com/

Vilas Ventures is an investment firm that offers venture capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Software | 1 | 33% |
| Health Care | 1 | 33% |
| Life Science | 1 | 33% |
| Medical Device | 1 | 33% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series C | 1 | 33% |
| Private Equity | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| CND Life Sciences | CND Life Sciences develops an accurate, evidence-based tool that helps confirm a diagnosis of synucleinopathy. CND launched the Syn-One Test, a commercially available test to detect, visualize, and quantify the presence of abnormal, phosphorylated alpha-synuclein in cutaneous nerve fibers. The test serves as an objective diagnostic tool to aid inthe confirmation of synucleinopathy in patients with suspected Parkinson’s disease (PD), dementia with Lewy body (DLB), multiple system atrophy (MSA), or pure autonomic failure (PAF).CND has research collaborations with multiple biopharmaceutical companies and is committed to advancing science in the field. |  | Private Equity | Aug 04, 2026 |  |
| CND Life Sciences | CND Life Sciences develops an accurate, evidence-based tool that helps confirm a diagnosis of synucleinopathy. CND launched the Syn-One Test, a commercially available test to detect, visualize, and quantify the presence of abnormal, phosphorylated alpha-synuclein in cutaneous nerve fibers. The test serves as an objective diagnostic tool to aid inthe confirmation of synucleinopathy in patients with suspected Parkinson’s disease (PD), dementia with Lewy body (DLB), multiple system atrophy (MSA), or pure autonomic failure (PAF).CND has research collaborations with multiple biopharmaceutical companies and is committed to advancing science in the field. | $13.5M | Series A | May 01, 2025 |  |
| Cortechs.ai | Cortechs.ai is a developer of brain image analysis software used to offer better clinical insight through quantitative imaging. It develops and markets cutting-edge brain imaging solutions that are used by neurologists and radiologists in hundreds of clinics and research centers around the world. Its software acts as a convenient and cost-effectivemeans to quantify brain structures that enable doctors in their assessment of a variety of neurological conditions, such as Alzheimer's disease, multiple sclerosis, epilepsy, and traumatic brain injury. |  | Series C | Nov 20, 2024 |  |

3 of 3 investments shown.

## Co-investors
- [Cambrian Capital Partners](https://shizune.co/investors/profile/cambrian-capital-partners) — VC Fund, 1 deal together
- Genting Berhad — VC Fund, 1 deal together
- Gold Bench Capital — VC Fund, 1 deal together
- [HonorHealth](https://shizune.co/investors/profile/honorhealth) — VC Fund, 1 deal together
- [LabCorp](https://shizune.co/investors/profile/laboratory-corporation-of-america) — VC Fund, 1 deal together
- Lupo Labs — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Vilas Ventures invest in?

Vilas Ventures invests primarily in Biotechnology, Software and Health Care startups, most often at Series A and Series C stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Vilas Ventures last invest?

The most recent investment recorded for Vilas Ventures closed in Aug 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co